Domestic and International Exchange Dynamics-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

International Life Extension Research Alliance

Domestic and International Exchange Dynamics

Video Center

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2026-08-14

→

Stem Cell-Derived Spinal Neurons Transplanted to Improve Respiratory Function in Rats, Providing New Evidence for Regenerative Therapy of Spinal Cord Injury

Before advancing toward clinical translation, follow-up work will need to validate efficacy in large animal models and assess therapeutic outcomes in late time windows—months to years post-injury—to reflect the most common clinical presentation timelines of patients seeking treatment.

2026-08-14

→

From DMSO to AI-Driven Rational Design: Borrowing from the Drug Discovery Paradigm to Unlock the "Vitrification Dilemma" in Organ Cryopreservation

By integrating the systematic optimization framework of drug discovery with a materials-science perspective, CPA design is evolving from empirical trial-and-error toward rational innovation. As "cryo-omics" data accumulate and AI tools mature, safer and more effective cryoprotectants and formulations are poised to emerge at an accelerated pace—paving the way for the long-term preservation of human cells, tissues, and ultimately whole organs.

2026-08-10

→

A Paradigm-Shifting Breakthrough: The "Cryo-Stasis" Framework Enables Low-Toxicity Vitrification of Small-Diameter Arterial Grafts

" It extends evaluation endpoints to nuclear envelope stability, tissue viscoelasticity, and post-transplant functionality. This work establishes a quantifiable experimental paradigm and a new technical starting point for the low-toxicity vitrification of viable vascular and complex tissues.

2026-07-22

→

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026-07-17

→

Landmark Breakthrough in Bioengineered Kidneys: High-Fidelity Renal Organoids Advance Toward Clinical Translation

While the journey from microscopic lab-grown organoids to transplantable, fully functional kidneys remains long, this study has undoubtedly unlocked a critical gateway to harnessing the “magic of development,” kindling new hope for millions of patients worldwide.

2026-07-17

→

Unlocking the Code of Hematopoietic Aging: Scientists Identify Novel Target to Reverse Immune Decline

This study not only elucidates a novel mechanism underlying hematopoietic aging but also offers promising new targets and therapeutic strategies for addressing age-related immunodeficiency, chronic inflammatory diseases, and even systemic aging itself. Looking ahead, precise modulation of this pathway may become a powerful tool for slowing the aging process and revitalizing the immune system.